Study testing for heart-shock to reduce future events
Part of Heart & circulation clinical trials.
This trial studies how to identify different types of “cardiogenic shock,” a serious drop in heart blood flow. It aims to use detailed patient information to guide care and possibly lower the chance of dangerous outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to under 75 years old
- Your blood pressure is very low, or you need medications that keep it up (like “vasoactive agents”)
- Your heart pumping strength (left ventricle ejection fraction) is 35% or less
- You have at least one sign that your body isn’t getting enough blood (like confusion, cold/sweaty skin, low mixed venous oxygen, high lactate, or low urine for hours)
- You have no reason you cannot receive “heart replacement therapy” (HRT) if needed
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses simple heart tests and blood markers to sort people with chronic heart failure into different risk levels, which may help guide treatment. You may join if you have heart failure symptoms and certain test findings.
This trial studies whether using a special pressure-monitoring tube in the heart’s main artery (a pulmonary artery catheter) helps people who are in cardiogenic shock from weak heart pumping. If you qualify, the goal is to improve how doctors monitor and treat this dangerous, fast-moving condition.
This trial studies specific body proteins to understand why fluid can leak from blood vessels during dangerous shock after infection or heart problems. If you (or your representative) qualify, your team will collect information and possibly samples to see whether these proteins relate to recovery and treatment response.
This study looks at people with a severe type of shock that affects both the heart and blood vessels, treated in the intensive care unit. It aims to understand how these patients recover and what factors impact their survival.
This registry tracks patients experiencing cardiogenic shock—a serious condition where the heart suddenly cannot pump enough blood to the body. Researchers collect information about patient outcomes and treatments to better understand what helps people recover.
This study tracks how well people with cardiogenic shock (a life-threatening drop in blood flow after a heart attack or heart failure worsening) do when treated with modern support devices and medicines.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.